Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China flag China · Delayed Price · Currency is CNY
6.32
+0.05 (0.80%)
Sep 4, 2026, 3:04 PM CST

Shanghai Kinetic Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
766.45946.1962.74933.631,1461,258
Other Revenue
10.7616.9721.7822.6319.7710.44
777.21963.06984.52956.261,1661,269
Revenue Growth
-26.31%-2.18%2.96%-17.99%-8.08%19.50%
Cost of Revenue
325.15487.17505.43466.09425.97490.52
Gross Profit
452.06475.9479.09490.17740.07778.06
Selling, General & Admin
303.4352.18348.72353.05436.31406.76
Research & Development
48.8951.4143.359.3461.469.77
Other Operating Expenses
1.656.755.566.9710.449.67
Operating Expenses
354.27415.96399.97410.4527.81497.7
Operating Income
97.859.9379.1279.78212.26280.36
Interest Expense
-1.67-7.47-6.67-6.56-14.12-22.66
Interest & Investment Income
91.8131.158.1746.4716.5627.8
Currency Exchange Gain (Loss)
-0.49-1.66-0.530.48-2.331.12
Other Non Operating Income (Expenses)
-1.19-3.27-3.37-4.26-4.17-2.76
EBT Excluding Unusual Items
186.2678.6876.73115.9208.2283.86
Impairment of Goodwill
-----197.99-149.26
Gain (Loss) on Sale of Investments
40.4356.75-195.071.19-28.935.25
Gain (Loss) on Sale of Assets
0.80.26-0.1-0.370.211.6
Asset Writedown
-2.39-0.38-2.91-0.58-2.01-0.14
Other Unusual Items
8.0810.1710.9917.4418.2344.93
Pretax Income
233.18145.48-110.37133.57-2.26216.31
Income Tax Expense
15.9313.86-14.156.9821.6941.31
Earnings From Continuing Operations
217.25131.62-96.22126.6-23.95175
Minority Interest in Earnings
7.763.27-9.35-14.062.67-13.22
Net Income
225.01134.89-105.57112.54-21.28161.78
Net Income to Common
225.01134.89-105.57112.54-21.28161.78
Net Income Growth
------
Shares Outstanding (Basic)
717717717717719722
Shares Outstanding (Diluted)
717717717717719722
Shares Change
-0.04%-0.01%0.05%-0.31%-0.40%-0.16%
EPS (Basic)
0.310.19-0.150.16-0.030.22
EPS (Diluted)
0.310.19-0.150.16-0.030.22
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
202.08122.8874.91220.47195.3328.94
Free Cash Flow Per Share
0.280.170.100.310.270.46
Dividend Per Share
0.1000.100-0.060-0.050
Dividend Growth
-----0%
Gross Margin
58.16%49.41%48.66%51.26%63.47%61.33%
Operating Margin
12.58%6.22%8.04%8.34%18.20%22.10%
Profit Margin
28.95%14.01%-10.72%11.77%-1.82%12.75%
Free Cash Flow Margin
26.00%12.76%7.61%23.06%16.75%25.93%
EBITDA
141.62109.31148.63145.6273.16337.18
EBITDA Margin
18.22%11.35%15.10%15.23%23.43%26.58%
D&A For EBITDA
43.8349.3869.5265.8360.956.81
EBIT
97.859.9379.1279.78212.26280.36
EBIT Margin
12.58%6.22%8.04%8.34%18.20%22.10%
Effective Tax Rate
6.83%9.53%-5.22%-19.10%
Revenue as Reported
416.97963.06984.52956.261,1661,269